Definitive Healthcare Corp. Class A Common Stock Earnings Recaps
Q3 2025
Nov 7, 2025
Definitive Healthcare reported Q3 2025 results with $60 million in revenue, slightly down from last year but exceeding guidance, driven by improved operational efficiency and customer retention rates.
Key takeaways
- Adjusted EBITDA reached $18.9 million, a margin of 32%, surpassing the high end of guidance by $2 million.
- Customer count remained stable at 2,400, with a notable increase of 10 enterprise customers, the highest level since Q3 last year.
- Continued focus on differentiated data led to significant wins in customer engagements, solidifying competitive advantages in the market.
- Year-over-year retention rates improved, reflecting positive trends in customer satisfaction and operational execution.
Q2 2025
Aug 8, 2025
Definitive Healthcare reported Q2 2025 results that exceeded expectations, reflecting improved renewal rates and strong operational efficiencies despite a year-over-year revenue decline.
Key takeaways
- Total revenue was $60.8 million, down 5% year-over-year but above guidance; early signs of improved renewal rates were noted.
- Adjusted EBITDA reached $18.7 million, representing a 31% margin, supported by disciplined expense management and scalable operations.
- New logo activity remained robust, indicating strong customer demand for the company's differentiated healthcare data solutions.
- Highest retention rate since Q2 of last year reinforces positive momentum, despite upcoming larger renewal periods in December and January.
- Guidance for revenue and adjusted EBITDA has been increased, reflecting confidence from first-half performance.